Infliximab was observed to bind firmly to CD14dim monocytes, granulocytes, and NK cells, hardly binding to CD8+ T cells or B cells, which might be related to expressing higher levels of membrane TNF (mTNF) in RA patients (31). The gene discussed is CD8A; the disease is rheumatoid arthritis.